Showing results (501-510 of 536) with videos related to

Sort By:
Pageof 54
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 20, 2012
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo armHicham Skali, Julie Lin, Marc A Pfeffer, et al.
Nature Communications|March 16, 2018
Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic plateletsLining Ju, James D McFadyen, Saheb Al-Daher, et al.
Diabetes|June 21, 2024
The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA SequencingAbdul Waheed Khan, Misbah Aziz, Karly C Sourris, et al.
Clinical Kidney Journal|September 3, 2021
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
Clinical Science (London, England : 1979)|February 3, 2016
Mapping time-course mitochondrial adaptations in the kidney in experimental diabetesMelinda T Coughlan, Tuong-Vi Nguyen, Sally A Penfold, et al.
Diabetes Care|March 30, 2004
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL StudyJuliana C N Chan, Nelson M S Wat, Wing-Yee So, et al.
Amino Acids|July 9, 2013
Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjectsJosephine M Forbes, Karly C Sourris, Maximilian P J de Courten, et al.
The Journal of Clinical Investigation|December 12, 2018
Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesisRaelene J Pickering, Christos Tikellis, Carlos J Rosado, et al.
Diabetes|January 10, 2018
Diabetes Reduces Severity of Aortic Aneurysms Depending on the Presence of Cell Division Autoantigen 1 (CDA1)Jiaze Li, Pacific Huynh, Aozhi Dai, et al.
Cardiovascular Diabetology|March 16, 2018
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal riskJulio Rosenstock, Vlado Perkovic, John H Alexander, et al.
Pageof 54